Gish Biomedical Inc.: The Irvine manufacturer of...
- Share via
Gish Biomedical Inc.: The Irvine manufacturer of surgical products said Monday that it has received Federal Food and Drug Administration approval to market MyoManager, its latest product to control the heart during open heart surgery. The company plans full market release of the MyoManager in November.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
